Guido Van Nooten
Overview
Explore the profile of Guido Van Nooten including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
385
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vanden Eynden F, El-Oumeiri B, Bove T, Van Nooten G, Segers P
Am J Physiol Heart Circ Physiol
. 2019 Feb;
316(5):H992-H1004.
PMID: 30767664
Locating the site of increased resistance within the vascular tree in pulmonary arterial hypertension could assist in both patient diagnosis and tailoring treatment. Wave intensity analysis (WIA) is a wave...
2.
El-Oumeiri B, Mc Entee K, Annoni F, Herpain A, Vanden Eynden F, Jespers P, et al.
BMC Cardiovasc Disord
. 2018 May;
18(1):99.
PMID: 29783950
Background: Aortic regurgitation (AR) is a valvular disease that can lead to systolic heart failure. Treatment options besides cardiac surgery are limited and consequently severe AR is associated with higher...
3.
Vanden Eynden F, Bove T, Chirade M, Van Nooten G, Segers P
Pulm Circ
. 2018 May;
8(2):2045894018776882.
PMID: 29708019
Arterial compliance (C) is related to the elasticity, size, and geometrical distribution of arteries. Compliance is a determinant of the load that impedes ventricular ejection. Measuring compliance is difficult, particularly...
4.
Lamotte M, Chimenti S, Deboeck G, Gillet A, Kacelenenbogen R, Strapart J, et al.
Acta Cardiol
. 2017 Aug;
73(3):248-255.
PMID: 28847218
Background: With more than 15,000 implanted patients worldwide and a survival rate of 80% at 1-year and 59% at 5-years, left ventricular assist device (LVAD) implantation has become an interesting...
5.
Nguyen T, Antoine M, Vanden Eynden F, Van Nooten G, El Oumeiri B
Acta Cardiol
. 2017 Aug;
73(3):303-304.
PMID: 28830305
No abstract available.
6.
Lootens L, Verbeke J, Martens T, Philipsen T, Caes F, Van Belleghem Y, et al.
Eur J Cardiothorac Surg
. 2017 Apr;
52(2):272-278.
PMID: 28430883
Objectives: Concerns have been raised about the durability of the first-generation Mitroflow aortic bioprosthesis (model 12 A-LX) due to the lack of anticalcification treatment. This study reflects a 10-year experience...
7.
Vanden Eynden F, Racape J, Vincent J, Vachiery J, Bove T, Van Nooten G
Respir Res
. 2016 Apr;
17:33.
PMID: 27036612
Background: In the pulmonary circulation, there is a linear relationship between systolic pulmonary arterial pressure (SPAP) and mean pulmonary arterial pressure (MPAP). The aim of this study was to determine...
8.
Roosens A, Somers P, De Somer F, Carriel V, Van Nooten G, Cornelissen R
Ann Biomed Eng
. 2016 Feb;
44(9):2827-39.
PMID: 26842626
To date an optimal decellularization protocol of heart valve leaflets (HVL) and pericardia (PER) with an adequate preservation of the extracellular matrix (ECM) is still lacking. This study compares a...
9.
Somers P, Roosens A, De Somer F, Cornelissen M, Van Nooten G
J Heart Valve Dis
. 2015 Jul;
24(1):92-100.
PMID: 26182626
Background And Aim Of The Study: Currently, no effective crosslinking reagents are available to treat xenogenic decellularized heart valve matrices. The study aim was to evaluate the crosslinking effect of...
10.
El Oumeiri B, Vanden Eynden F, Van Nooten G
Int J Surg Case Rep
. 2015 Feb;
8C:158-60.
PMID: 25697401
Introduction: We describe an unusual durability of a Hancock II porcine bioprosthesis in tricuspid position. Sustainability of bioprostheses is known to be limited especially in young patients. Presentation Of The...